JP Patent

JP5584705B2 — Ｒ）−３−（４−（２−（２−メチルテトラゾール−５−イル）ピリジン−５−イル）−３−フルオロフェニル）−５−ヒドロキシメチルオキサゾリジン−２−オンリン酸二水素の結晶形

Assigned to トリウスセラピューティクス · Expires 2014-09-03 · 12y expired

What this patent protects

Patent listed against tedizolid-phosphate.

Drugs covered by this patent

tedizolid-phosphate (TEDIZOLID PHOSPHATE)

Patent Metadata

Patent number: JP5584705B2
Jurisdiction: JP
Classification: —
Expires: 2014-09-03
Drug substance claim: No
Drug product claim: No
Assignee: トリウスセラピューティクス
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.